Could a cholesterol drug boost chemo in resistant lung cancer?
Disease control
Not yet recruiting
This early-phase trial is for people with non-small cell lung cancer that has stopped responding to second-line treatment. Researchers will use a lab test on a patient's own tumor cells to pick the best chemotherapy drugs, then add the statin pitavastatin. The goal is to see if t…
Phase: PHASE1 • Sponsor: Chang Chen • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC